T spot TB reagents and test kits
Ended Awarded Last action
- Contract number
- 36C24225N0127
- Awardee
-
Euroimmun US Incorporated UEI TLRGC9WLG3U7 Part of Revvity Inc.
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $54,396
Award facts
- Opportunity
-
- 6550--INTENT TO AWARD SOLE SOURCE T-SPOT. TB Testing - Buffalo Special Notice · 36C24221Q1066 · Posted Jun 24, 2021
- Contract value 100% obligated
- $54,395.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mountain Lakes, NJ 07046, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$53,705 | |
| Original award | $108,101 |
About this award
Euroimmun US Incorporated, a subsidiary of Revvity Inc., has been awarded a delivery order valued at $54,395.60 under a Blanket Purchase Agreement with the Veterans Integrated Service Network 2 for T-SPOT TB reagents and test kits. The award, made on October 1, 2024, is a firm fixed-price contract with an ultimate completion date of September 30, 2025, and will be performed in Mountain Lakes, New Jersey. This contract does not utilize a set-aside designation, indicating it was awarded through open competition. The T-SPOT TB reagents represent critical diagnostic tools for tuberculosis screening within the Veterans Health Administration, supporting the VA's preventative health initiatives for the veteran population.
This delivery order is executed under the existing $1.1 million Blanket Purchase Agreement between Euroimmun US Incorporated and VISN 2, which runs through September 2026 and encompasses T-SPOT TB reagents and related services. As a wholly owned subsidiary of Revvity Inc., a leader in medical diagnostics and laboratory testing equipment, Euroimmun provides sophisticated immunodiagnostic systems and specialized medical screening technologies to multiple federal agencies including the Department of Veterans Affairs, Department of the Army, Centers for Disease Control and Prevention, and the National Institutes of Health. The company's established federal contract portfolio and specialized expertise in tuberculosis diagnostic reagents position it as a consistent supplier of critical medical diagnostic products to federal healthcare organizations.
Quick answers
Who was awarded contract 36C24225N0127?
36C24225N0127 was awarded to Euroimmun US Incorporated by Veterans Integrated Service Network 2 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C24225N0127 worth?
The government has obligated $54,396 on 36C24225N0127.
Is contract 36C24225N0127 an order under another contract?
Yes. 36C24225N0127 is a BPA call under 36C24222A0001, a blanket purchase agreement.
Was contract 36C24225N0127 competed?
The extent of competition for 36C24225N0127 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award